These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10371421)

  • 21. What can SV40-derived vectors do for gene therapy?
    Strayer DS; Zern MA; Chowdhury JR
    Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of herpes simplex virus vectors through liposome formulation.
    Fu X; Zhang X
    Mol Ther; 2001 Nov; 4(5):447-53. PubMed ID: 11708881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Dressed-up" naked plasmids: emerging vectors for non-viral gene therapy.
    Gôrecki DC
    Discov Med; 2006 Oct; 6(35):191-7. PubMed ID: 17234141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parvovirus vectors: use and optimisation in cancer gene therapy.
    Blechacz B; Russell SJ
    Expert Rev Mol Med; 2004 Jul; 6(16):1-24. PubMed ID: 15387896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biophysical targeting of adenovirus vectors for gene therapy.
    Silman NJ; Fooks AR
    Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of retroviral vectors and helper cells for gene therapy.
    Hu WS; Pathak VK
    Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted gene delivery to the lung.
    Aneja MK; Geiger JP; Himmel A; Rudolph C
    Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What role can chemistry play in cationic liposome-based gene therapy research today?
    Kostarelos K; Miller AD
    Adv Genet; 2005; 53():71-118. PubMed ID: 16240991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimuli-responsive gene delivery vectors.
    Oupický D; Diwadkar V
    Curr Opin Mol Ther; 2003 Aug; 5(4):345-50. PubMed ID: 14513676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of liposomes to hepatocytes.
    Ghosh PC; Bachhawat BK
    Targeted Diagn Ther; 1991; 4():87-103. PubMed ID: 1724610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of liposomes as delivery systems in veterinary medicine.
    Sallovitz JM; Zonco Menghini MI; Lanusse CE
    Vet Res; 1998; 29(5):409-30. PubMed ID: 9779555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The liver-cell specific drug delivery system].
    Goto M
    Nihon Rinsho; 1994 Aug; 52(8):2214-24. PubMed ID: 7933613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell].
    Cavagnari BM
    Arch Argent Pediatr; 2011 Jun; 109(3):237-44. PubMed ID: 21660389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug targeting to the diseased liver.
    Poelstra K; Prakash J; Beljaars L
    J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of drugs to the liver.
    Meijer DK; Molema G
    Semin Liver Dis; 1995 Aug; 15(3):202-56. PubMed ID: 7491504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Liposomes as non-viral carriers for genetic drugs].
    Meissner JM; Toporkiewicz M; Matusewicz L; Machnicka B
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():200-9. PubMed ID: 27117095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology.
    Omidi Y; Barar J; Akhtar S
    Curr Drug Deliv; 2005 Oct; 2(4):429-41. PubMed ID: 16305446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.